Japan Approves Anti-Viral By Australia's Biota With Daiichi Sankyo
This article was originally published in PharmAsia News
Executive Summary
Japanese regulators have approved Australian drug maker Biota's Inavir (laninamivir) as a treatment for influenza and other viruses